-
See you at our Stall No. 4H20 in CPHI INDIA
Read more -
Analysis of the layout of anti cancer drugs in China: ten billion market is surging
Among many antitumor drugs, tinii plays a very important role. Statistics show that China’s sales of tinibacin drugs in 2018 will exceed 10 billion yuan, in front of such a big cake, the major pharmaceutical companies have layout, the market is surging. Now let’s take a look at these ...Read more -
Tini series antitumor drugs
Tinidine antitumor drugs are a new class of biotargeted antitumor drugs. Currently, the common antitumor drugs of tinidine in China’s market include: gefitinib, imatinib, imatinib mesylate, nilotinib, sunitinib and lapatinib. Gefitinib, developed by astrazeneca, UK, is the first molecular t...Read more -
China CPhI China will open its gates again on 20 – 22 June 2018
CPhI China – The leading pharmaceutical ingredients show in China and wider Asian – Pacific region. “CPhI China is a great way to tap into the market and connect with the potential suppliers from all over the world. Aside from networking with existing suppliers, it provides an o...Read more